Case File №
#VI-2026-0381
Xingtai Lesda Technology
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
41 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | E Bad | 6 | 6.6 | 0.0 | 10.0 | 1 Sep 2025 |
| AA Water | X N/A | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 |
| Abaloparatide | X N/A | 1 | 10.0 | 10.0 | 10.0 | 16 Mar 2025 |
| ACE-031 | X N/A | 1 | 4.6 | 4.6 | 4.6 | 28 Mar 2025 |
| APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | X N/A | 1 | 8.4 | 8.4 | 8.4 | 21 May 2025 |
| BAC Water | X N/A | 1 | 8.6 | 8.6 | 8.6 | 3 Jun 2025 |
| BAM15 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 6 May 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 5.8 | 5.8 | 5.8 | 11 Jun 2025 |
| BPC-157 Arg Oral | X N/A | 1 | 4.4 | 4.4 | 4.4 | 16 Mar 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 6.6 | 6.6 | 6.6 | 20 Jun 2025 |
| Cardiogen | X N/A | 1 | 5.1 | 5.1 | 5.1 | 20 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 5.5 | 5.5 | 5.5 | 28 Mar 2025 |
| CJC-1295 With DAC | X N/A | 1 | 6.3 | 6.3 | 6.3 | 6 May 2025 |
| Crystagen | X N/A | 1 | 6.4 | 6.4 | 6.4 | 27 Feb 2025 |
| Dutasteride | X N/A | 1 | 5.3 | 5.3 | 5.3 | 7 May 2025 |
| Epithalon | X N/A | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 |
| EPO | X N/A | 1 | 6.9 | 6.9 | 6.9 | 9 Jun 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 7.0 | 7.0 | 7.0 | 6 May 2025 |
| FOXO4 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 3 Jun 2025 |
| GHRP-2 Acetate | X N/A | 1 | 5.6 | 5.6 | 5.6 | 7 May 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 5.7 | 5.7 | 5.7 | 17 Dec 2024 |
| Ivermectin | X N/A | 1 | 9.1 | 9.1 | 9.1 | 3 Jul 2025 |
| KPV | X N/A | 1 | 4.0 | 4.0 | 4.0 | 20 Jun 2025 |
| Lipo-C 120mg | X N/A | 1 | 6.6 | 6.6 | 6.6 | 13 Feb 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 4.9 | 4.9 | 4.9 | 3 Jun 2025 |
| Methylene Blue | X N/A | 1 | 7.5 | 7.5 | 7.5 | 17 Dec 2024 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 8.3 | 8.3 | 8.3 | 3 Jul 2025 |
| Selank | X N/A | 1 | 5.4 | 5.4 | 5.4 | 8 Jul 2025 |
| Semax | X N/A | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 |
| SLU-PP-332 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 |
| Super Shred | X N/A | 1 | 5.2 | 5.2 | 5.2 | 2 Jul 2025 |
| T3 (Liothyronine) | X N/A | 1 | 8.5 | 8.5 | 8.5 | 16 Mar 2025 |
| Tamoxifen (Nolvadex) | X N/A | 1 | 7.1 | 7.1 | 7.1 | 2 Apr 2025 |
| Telmisartan | X N/A | 1 | 6.7 | 6.7 | 6.7 | 28 Mar 2025 |
| Testosterone Decanoate Raw | X N/A | 1 | 7.2 | 7.2 | 7.2 | 6 May 2025 |
| Thymalin | X N/A | 1 | 5.8 | 5.8 | 5.8 | 27 Feb 2025 |
| Tirzepatide 30mg Pen Kit | X N/A | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 |
| Trenbolone Enanthate | X N/A | 1 | 4.8 | 4.8 | 4.8 | 2 Apr 2025 |
| Vilon | X N/A | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 |
| Winstrol Oil (Stanozolol) | X N/A | 1 | 5.0 | 5.0 | 5.0 | 2 Apr 2025 |
| YK-11 Raw | X N/A | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 |
Exhibit II
Evidence Log
46 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | BPC157 5mg + TB500 5mg Blend | 7.7 A | 20mg | 24.9mg | +24.7% | 98.43% | skg5nr | Lab B | Public |
| 24 May 2026 | Selank | 6.7 A | 20mg | 17.4mg | -13.1% | 98.00% | zrqco2 | Lab C | Public |
| 24 May 2026 | Abaloparatide | 10.0 A | 30mg | 28.3mg | -5.6% | 99.59% | ntw8mi | Lab G | Public |
| 24 May 2026 | T3 (Liothyronine) | 7.5 A | 10mg | 11.5mg | +14.9% | 99.65% | qddhx0 | Lab C | Community |
| 24 May 2026 | Vilon | 6.4 A | 20mg | 17.4mg | -12.9% | 96.69% | k6jakr | Lab F | Public |
| 23 May 2026 | Crystagen | 5.3 B | 15mg | 16.6mg | +10.7% | 97.42% | avgois | Lab B | Community |
| 23 May 2026 | Super Shred | 5.9 B | 250mg/ml | 236.1mg/ml | -5.6% | 97.51% | c9fke9 | Lab C | Public |
| 23 May 2026 | BPC-157 Arg Oral | 5.5 B | 100mg | 105.6mg | +5.6% | 99.03% | c2usic | Lab C | Public |
| 23 May 2026 | Tirzepatide 30mg Pen Kit | 6.1 A | 20mg | 24.5mg | +22.7% | 96.40% | d1rdbm | Lab F | Public |
| 23 May 2026 | YK-11 Raw | 6.9 A | 10g | 9.8g | -1.7% | 99.50% | 3yqy8h | Lab F | Community |
| 21 May 2026 | Tamoxifen (Nolvadex) | 6.7 A | 25mg | 25.1mg | +0.3% | 99.13% | ccmx9o | Lab D | Public |
| 20 May 2026 | CJC-1295 With DAC | 7.4 A | 10mg | 9.3mg | -6.8% | 98.76% | mkampu | Lab F | Public |
| 19 May 2026 | Ivermectin | 10.0 A | 20mg | 23.9mg | +19.6% | 99.49% | hi4tpz | Lab B | Public |
| 17 May 2026 | Halotestin (Fluoxymesterone) | 5.3 B | 20mg | 22.2mg | +11.1% | 96.74% | 9a12bn | Lab F | Public |
| 17 May 2026 | Thymalin | 7.5 A | 5mg | 4.9mg | -2.6% | 95.70% | h2pou4 | Lab F | Community |
| 29 Jan 2026 | BAM15 | 5.6 B | 100mg | 100.4mg | +0.4% | 99.91% | pkckjb | Lab C | Public |
| 29 Jan 2026 | Semax | 4.2 C | 30mg | 29.2mg | -2.7% | 98.29% | zsc7lr | Lab D | Public |
| 26 Jan 2026 | Blend 300 (TRA/Mast P/Test P) | 5.7 B | 300mg/ml | 330.4mg/ml | +10.1% | 97.54% | 4n7br0 | Lab C | Public |
| 26 Jan 2026 | Masteron P (Drostanolone P) | 5.6 B | 250mg/ml | 232.7mg/ml | -6.9% | 99.74% | y117cc | Lab E | Community |
| 9 Jan 2026 | AA Water | 10.0 A | 2mg | 2.4mg | +20.1% | 95.96% | id1j1d | Lab D | Public |
| 9 Jan 2026 | Retatrutide 30mg Pen Kit | 6.6 A | 2mg | 1.9mg | -6.3% | 95.61% | b4vx52 | Lab B | Public |
| 9 Jan 2026 | Telmisartan | 5.7 B | 100mg | 104.6mg | +4.6% | 98.00% | hgura5 | Lab F | Public |
| 6 Jan 2026 | APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | 7.8 A | 500g | 484.3g | -3.1% | 99.82% | w5r8tg | Lab G | Community |
| 6 Jan 2026 | Trenbolone Enanthate | 4.0 C | 200mg/ml | 245.2mg/ml | +22.6% | 95.30% | wkk1vb | Lab G | Community |
| 29 Dec 2025 | Winstrol Oil (Stanozolol) | 6.3 A | 200mg/ml | 246.0mg/ml | +23.0% | 96.03% | nu7y5g | Lab A | Community |
| 12 Dec 2025 | Testosterone Decanoate Raw | 6.8 A | 5g | 4.3g | -14.2% | 98.99% | 3jwd29 | Lab F | Community |
| 5 Dec 2025 | Equipoise (Boldenone Undecylenate) | 7.6 A | 200mg/ml | 176.8mg/ml | -11.6% | 99.80% | tpnlcm | Lab G | Public |
| 23 Nov 2025 | Dutasteride | 5.8 B | 10mg | 11.2mg | +11.9% | 97.12% | gej5g7 | Lab B | Public |
| 17 Nov 2025 | Cardiogen | 7.0 A | 15mg | 17.1mg | +13.9% | 97.84% | ra03ba | Lab E | Public |
| 17 Nov 2025 | Lipo-C 120mg | 6.6 A | 100mg/ml | 116.0mg/ml | +16.0% | 96.40% | af1bbe | Lab G | Community |
| 14 Nov 2025 | Epithalon | 6.3 A | 2mg | 2.4mg | +21.1% | 97.95% | wi53nl | Lab E | Public |
| 14 Nov 2025 | FOXO4 | 5.9 B | 10mg | 9.8mg | -2.0% | 98.08% | i734fk | Lab A | Community |
| 5 Nov 2025 | Methylene Blue | 6.3 A | 50mg | 52.5mg | +5.0% | 98.16% | v6a2gy | Lab D | Community |
| 4 Nov 2025 | ACE-031 | 4.0 C | 5mg | 6.0mg | +20.7% | 98.72% | opxbv2 | Lab D | Community |
| 23 Oct 2025 | Retatrutide | 10.0 A | 10mg | 9.68mg | -3.2% | 99.88% | RT10-DM | Lab E | Public |
| 21 Oct 2025 | Retatrutide | 7.0 A | 10mg | 10.1mg | +1.0% | 99.51% | (no batch ID) | Lab E | Public |
| 17 Oct 2025 | GHRP-2 Acetate | 4.6 C | 50mg | 60.6mg | +21.2% | 95.55% | ib6gwd | Lab B | Public |
| 17 Oct 2025 | SLU-PP-332 | 4.9 C | 10mg | 9.3mg | -7.2% | 97.80% | 2qer73 | Lab F | Community |
| 9 Oct 2025 | Cerebrolysin | 5.9 B | 15mg | 13.4mg | -10.4% | 95.22% | dsek7o | Lab D | Public |
| 5 Oct 2025 | Retatrutide | 0.0 E | 10mg | ⚠️ Sample does not contain Retatrutide | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | — | — |
| 3 Oct 2025 | Retatrutide | 7.4 A | 5mg | 4.71mg | -5.8% | 99.75% | (no batch ID) | Lab E | Public |
| 3 Oct 2025 | BAC Water | 10.0 A | 15mg | 13.5mg | -9.9% | 95.71% | moaein | Lab G | Public |
| 3 Oct 2025 | EPO | 6.6 A | 10mg | 8.8mg | -12.3% | 97.83% | bei3rr | Lab B | Public |
| 3 Oct 2025 | KPV | 4.0 C | 5mg | 5.7mg | +14.5% | 99.01% | vuc23r | Lab G | Public |
| 10 Sep 2025 | Retatrutide | 9.0 A | 5mg | 4.62mg | -7.6% | 99.83% | RT508112025 | Lab E | Public |
| 1 Sep 2025 | Retatrutide | 6.2 B | 5mg | 6.17mg | +23.4% | 99.59% | RT508112025 | Lab F | Public |
— END OF EVIDENCE LOG —